Magnetar Financial LLC Exact Sciences Corp Transaction History

Magnetar Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $283,802 - $497,005	9,351 New	9,351 $463,000
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $466,491 - $998,613	13,100 New	13,100 $516,000
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $750,955 - $1.04 Million	-10,358 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $934,705 - $1.28 Million	10,358 New	10,358 $989,000
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $214,358 - $356,623	-3,845 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$37.9 - $104.44 $145,725 - $401,571	3,845 New	3,845 $223,000
Q4 2019 Feb 13, 2020	SELL	$77.66 - $99.74 $998,008 - $1.28 Million	-12,851 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $1.16 Million - $1.57 Million	12,851 New	12,851 $1.16 Million

666

152M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.36B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.